Peak oxygen uptake (VO 2peak ), a measure of aerobic exercise capacity, predicts mortality and morbidity in healthy and diseased individuals. Our aim was to determine VO 2peak years after paediatric allogeneic haematopoietic SCT (HSCT) and to identify associations with baseline patient and donor characteristics, transplantation factors, pulmonary function and self-reported sports activity. In this cross-sectional, population-based study, we measured VO 2peak , spirometry and diffusion capacity of the lung (D LCO ) 3-10 years post HSCT. Z-scores were calculated by reference values from healthy subjects. Self-reported hours of sports activity were obtained by interview. We included 63 patients (mean age (range) 14.4 (7-24) years). HSCT patients exhibited lower mean VO 2peak (−1.42 z-score, 95% confidential interval (−1.7; − 1.1)) compared with healthy subjects (Po 0.001). Sixteen patients (25%) had VO 2peak values o − 1.96 z-score. Low VO 2peak was associated with reduced forced expiratory volume in 1 s (R 2 = 0.11, P = 0.009), reduced D LCO /V A (R 2 = 0.09, P = 0.01) and low physical activity (mean VO 2peak z-score inactive group: − 2.1 vs most active group: − 1.1, P = 0.02). No associations between VO 2peak and diagnosis, donor type or GvHD were found. Although causes for reduced VO 2peak may be multiple, our findings stress the need to focus on physical activity post HSCT to prevent lifestyle diseases and improve quality of life.
INTRODUCTION
The population of long-term survivors after allogeneic haematopoietic SCT (HSCT) has increased owing to advances in donor selection and improvements in conditioning regimens and supportive care. Improved survival has increased the focus on late effects and quality of life. 1 HSCT may affect multiple organ systems as a result of the toxicity from chemotherapy, TBI and complications including GvHD and infections. 1 In a recent retrospective study, we documented reduced spirometric values in 34% of paediatric patients more than 18 months from HSCT. 2 However, little is known about the potential consequences of reduced pulmonary function for daily life activities and aerobic exercise capacity.
Peak oxygen uptake (VO 2peak ) is a measure of physical capacity, which integrates the responses of the cardiovascular, pulmonary and musculoskeletal systems when faced with physical requirements; 3 thus, VO 2peak allows evaluation of abnormalities, which may not be apparent during rest. 4 As a measure of cardiorespiratory fitness, VO 2peak is a powerful predictor of morbidity and mortality in both healthy and diseased individuals. 5, 6 In cancer patients, reduced VO 2peak has been associated with fatigue, which is known to reduce the quality of life, especially in children and young adults for whom physical activities are an essential part of the daily routine. 7 A recent systematic review revealed slightly reduced VO 2peak in survivors of childhood leukaemia compared with healthy controls. 8 Although HSCT has been described as the treatmentvariable most consistently associated with reduced VO 2peak following childhood leukaemia, 9 only three older studies in a limited number of patients have investigated exercise capacity at long-term follow-up after paediatric HSCT. They found VO 2peak to be moderately reduced. [10] [11] [12] However, the relation between pulmonary function and VO 2peak has not been investigated and no conclusive results regarding potential associations between transplantation-related factors and VO 2peak have been presented. [10] [11] [12] The aim of this study was to determine exercise capacity by VO 2peak at long-term follow-up after paediatric allogeneic HSCT, and to investigate associations between exercise capacity, pulmonary function, transplantation characteristics and selfreported level of physical sports activity.
MATERIALS AND METHODS Design
This study was part of a cross-sectional, population-based follow-up study of Danish children and young adults 3-10 years after myeloablative allogeneic HSCT with focus on pulmonary function and aerobic exercise capacity.
Patient population
Patients undergoing myeloablative HSCT in Denmark between 2002 and 2009 before the age of 16 years, who were older than 6 years of age and in full remission at the time of the study, were eligible. Patients were identified through the National Danish HSCT database.
Exclusion criteria were reduced ability to give informed consent owing to language difficulties and inability to cooperate to examinations. Testing was postponed if the participant had a respiratory tract infection or a temperature 438°C within 14 days of examination.
Examinations
Exercise test. Aerobic exercise capacity (VO 2peak (mL/min/kg)) was measured during an incremental exercise test on an electronically braked cycle ergometer. Two sizes of cycle ergometers were available (Tecnogym Bike Med D827, Gambettola, Italy and Lode Corrival Pediatric Intramedic, Groningen, The Netherlands)). Using a face mask and a two-way valve (Hans Rudolph, Shawnee, KS, USA), expired air was led to a mixing chamber where O 2 and CO 2 concentrations were analysed by mass spectrometry (Amis 2000; Innovision, Odense, Denmark). Heart rate (HR) and oxygen saturation (SAT) were monitored by pulse oximetry (Polar, Kempele, Finland and BITMOS GmbH, Düsseldorf, Germany).
An individual exercise protocol was defined with increments of 10, 15 or 20 W/min based on the patient's height and pulmonary function. 13 Initial workload was determined by HR response during warm-up and the aim of a test duration between 6 and 10 min. Patients were encouraged to continue exercising throughout the test despite signs of exhaustion.
The criteria for a peak exercise test were maximal HR40.85 × (220-age in years) or a respiratory exchange ratio 41.0 plus subjective and objective signs of exhaustion.
3,14 VO 2peak was defined as the mean of the two highest and consecutive measures in the last minute of the test.
VO 2peak was the main outcome of the test. In addition, indicators of pulmonary limitation to exercise were calculated: the ventilatory reserve (VR) reflecting ventilatory capacity and the ventilatory equivalent for CO 2 (V eqCO 2 ) reflecting efficiency of ventilation. 3 We used age-and gender-specific reference values for VO 2peak derived from six Danish and Norwegian studies of healthy children and young adults, [15] [16] [17] [18] [19] [20] which included measurements in a total of 1041 females and 1061 males across all ages of interest (6-24 years). The reference material was validated by testing 33 healthy subjects (17 males and 16 females) equally distributed in the age group 6-30 years with the same equipment and protocol as used in the patient population. The healthy subjects had normal spirometry and no history of atopy or heart or lung disease.
Pulmonary function tests. Spirometry and diffusion capacity of the lung for carbon monoxide (D LCO ) were performed according to the European Respiratory Society guidelines 21, 22 using the MasterScreen PFT Pro apparatus (CareFusion, Hoechberg, Germany). D LCO reflecting the total diffusion capacity of the lung was calculated as the product of the measured alveolar volume (V A ) and the gas transfer coefficient D LCO /V A (the uptake of carbon monoxide per V A ). D LCO and D LCO /V A were corrected for Hb measured at the day of examination (Hemocue Hb 201+; Hemocue, Vedbaek, Denmark). 23 Stanojevic et al. 24 reference equations were used for spirometric parameters. Koopman et al. 25 reference equations were used for D LCO and D LCO /V A and extrapolated to ages above 18 years to avoid an artificial variance between age groups arisen from differences between reference materials. All reference equations for pulmonary function parameters were gender, age and height specific.
Clinical data
Patient data were obtained from patient files and the Danish reports to the Centre for International Blood and Marrow Transplant Research. Transplantation characteristics included age at HSCT, diagnosis, donor type (HLA-identical sibling, matched-unrelated donor (9/10 or 10/10 match) or -unrelated donor (41 allele mismatch)), donor age and gender, CMV Ab status for recipients and donors, graft source, acute (aGvHD) and chronic GvHD (cGvHD), chemotherapy (BU, etoposide and CY) and TBI. The presence of cGvHD was assessed according to the National Institutes of Health's consensus criteria 26 on the day of examination.
Self-reported fitness level and level of physical activity
Before examination, the patients were asked to rate their fitness level as either below normal, normal or above normal compared with their peers and classmates and to report weekly hours of organized sports activity: 0, 1-3 or more than 3 h.
Statistics
All statistics were performed using R version 2.15.0 software (R Foundation for Statistical Computing, Vienna, Austria). 27 Descriptive statistics included mean, range and 95% confidential intervals (95% CI). Z-scores for VO 2peak and pulmonary function parameters were calculated as: (measured value − age-and gender-specific reference value)/s.d. of the reference population. Upper and lower limits of normal were defined as z-scores above 1.96 and below − 1.96, respectively.
Welch t-test was performed for categorial data and linear regression for continuous parameters. Covariates with P-values o0.10 in the univariate analysis were included in a multiple linear regression analysis performed by stepwise forward selection. Because of colinearity between several of the pulmonary function parameters, only forced expiratory volume in 1s (FEV 1 ) and D LCO /V A were entered in the multivariate analysis. P-values o0.05 were considered statistically significant.
Ethics
The study was approved by the Danish National Committee on Health Research Ethics (J. no. H-2-2011-164) and the Danish Data Protection Agency (J. no. 2007-58-0015). Informed written consent was obtained from all participants or from legal guardians for patients younger than 18 years.
RESULTS

Population characteristics
We identified 96 eligible patients, of whom 70 (73%) participated ( Figure 1 ). Seven exercise tests were considered invalid owing to suboptimal cooperation; accordingly, 63 patients were included in the statistical analysis.
Characteristics of the study population are presented in Table 1 . Twenty-seven patients received treatment for endocrinopathies at the time of the study: 25% (16/63) for hypothyroidism, 11% (7/63) for growth hormone deficiency and 11% (7/63) of males and 42% of females for sex hormone deficiencies.
There were no significant differences between participants and non-participants/excluded patients with respect to gender, current age, age at HSCT, years from HSCT, diagnosis, donor age, donor type, stem cell source and aGvHD. A higher proportion of non-participants compared with participants received BU as part of the conditioning (72.7% vs 46.0%, P = 0.01).
Exercise test All tests were performed by the same two investigators. All included patients performed a test that met the criteria for a peak exercise test (see Materials and methods) even though 10 patients had test durations o 6 min. Desaturation (SAT o 90%) occurred in two patients during the test to a minimum SAT of 86% and 88%, respectively. One patient exhibited signs of bronchoconstriction during exercise with a subsequent decline of 26% in FEV 1 .
The reference material was accepted as reliable as 32/33 healthy subjects exhibited exercise test results within the upper and lower limit of normal.
The VO 2peak z-scores for the patients and the healthy subjects are presented in Figure 2 , and the results of the exercise tests are summarized in Table 2 . Sixteen patients (25%) had VO 2peak below LLN. The mean VO 2peak z-score of the HSCT patients was significantly below the reference mean (P o 0.001) and the mean of the group of healthy subjects (P o 0.001).
VR was abnormally low in eight patients (13%) and V eqCO 2 abnormally high in seven patients (11%).
Pulmonary function tests Spirometry and D LCO measurements were obtained in 62/63 and 61/63 patients, respectively. The mean pulmonary function test values were significantly below the reference means for all parameters except maximum midexpiratory flow. However, the majority of patients presented pulmonary function test values within normal limits ( Figure 3 ) and no patients had obstructive patterns (FEV 1 /forced vital capacity (FVC) o 0.7).
Self-reported fitness level and physical activity The patients rated their fitness level compared with peers except one patient who refused (Figure 4a ). The mean VO 2peak z-score differed significantly among the three groups (P o 0.001), being lowest in the group of patients that reported having a lower fitness level than their peers and highest in the group that reported having a higher fitness level than their peers.
Furthermore, the patients reported hours per week spent on organized sports activity (Figure 4b ). The patients that reported zero hours of sports activities per week had significantly lower mean VO 2peak compared with those reporting more than 3 h of weekly exercise (−2.1 vs − 1.1 z-score, P = 0.02).
Associations between VO 2peak , patient and transplantation characteristics and pulmonary function tests Results from all analyses are presented in detail in Table 3 . In univariate analyses, VO 2peak was negatively associated with BMI zscore (P = 0.002, R 2 = 0.15) and positively associated with the patient height z-score (P = 0.02, R 2 = 0.09). Furthermore, VO 2peak z-score was found negatively, but weakly associated with patient age at the time of HSCT (P = 0.044, R 2 = 0.065). No associations were observed between VO 2peak and other transplantation parameters such as diagnosis, type of donor, conditioning regimen or aGvHD.
Five patients (8%) had manifestations of cGvHD at the time of examination, including lichenization of the oral mucosa (n = 4), xerostomia (n = 1), dryness of the eyes (n = 2), erythema (n = 1), scalp alopecia (n = 1) and nail dystrophy (n = 1). Of those five patients, one patient had impaired pulmonary function (FEV 1 = 57%, D LCO = 70% of normal values), but did not fulfil the National Institute of Health's consensus criteria for bronchiolitis obliterans syndrome. 26 The presence of cGvHD at the time of assessment (n = 5) or previous to the assessment (n = 10) was not associated with VO 2peak values. VO 2peak z-score was associated with FEV 1 , FVC, D LCO and D LCO /V A z-scores in the univariate analyses (Table 3 ). The final multiple linear regression model (adjusted R 2 = 0.53) confirmed significant associations between VO 2peak and FEV 1 , D LCO /V A and BMI (Table 3) .
DISCUSSION
This study demonstrated that 25% of patients had reduced aerobic exercise capacity assessed by VO 2peak 3-10 years after HSCT in childhood. The reduced VO 2peak was associated with impaired pulmonary function and low self-reported physical activity.
Three previous studies have found reduced exercise capacity at long-term follow-up after paediatric HSCT. In 31 patients (age 6-32 years), Larsen et al. 10 found that 55% of patients had VO 2peak below − 1.64 z-score at a mean (range) follow-up of 3.9 years (11 months-12 years). Eames et al.
11 estimated VO 2peak values from a treadmill exercise test and found values o70% of predicted in 42% of their cohort of 31 patients (age 9-32 years) at a mean (range) of 4.1 years (1-16 years) after HSCT. Hogarty et al. 12 found reduced VO 2peak values before and after transplantation with a slight amelioration from early follow-up to a mean VO 2peak of 69% of predicted 5 years post-HSCT.
These three studies assessed VO 2peak in patients transplanted from 1975 to 1995, and overall they found a higher proportion of patients with abnormally reduced VO 2peak and lower mean VO 2peak values compared with our study. However, the studies were not directly comparable to our study due to smaller sample sizes, differences in study design, methods and length of followup. Moreover, conditioning, GvHD prophylaxis and supportive regimens have improved considerably within the past decade including less intensive regimens, most likely reducing the risk of pulmonary morbidity and impaired functional capacity following HSCT. Low VO 2peak may reflect several different physical limitations, including respiratory, cardiac and musculoskeletal problems or combinations of those. 3 To our knowledge, this is the first report on the association between low VO 2peak and reduced pulmonary function in paediatric HSCT patients. Furthermore, we found abnormal values of VR and ventilatory equivalent of CO 2 supporting the hypothesis that pulmonary limitations are at least partly responsible for the low VO 2peak in these patients.
Previously, reduced pulmonary function in combination with reduced VO 2peak have been reported in survivors of childhood leukaemia 9 for whom HSCT was the treatment parameter most strongly associated with impaired exercise capacity at a mean (range) of 4.2 (0.6-18.5) years after treatment.
Hovi et al. 28 recently documented that reduced physical performance in children and young adults 4-16 years after HSCT was associated with reduced strength, endurance and flexibility of the larger muscle groups. Direct effects of chemotherapy and radiation, as well as indirect effects such as endocrine dysfunction, may contribute to this impairment. 1, 28 Growth hormone deficiency was present in 11% of our patients. Although the mean height, weight and BMI z-scores of our patients were close to normal, the range was quite large, and VO 2peak was associated with patient BMI and height z-scores in univariate analyses. Twenty-three percent of our cohort was treated for sex hormone deficiency. Through puberty, VO 2peak rises in boys, whereas VO 2peak stabilizes or declines in girls.
14 Thus, a measure of puberty grade could have elucidated whether delayed puberty affected VO 2peak in our cohort, but this was not included in the investigation.
In line with the report from Hovi et al., 28 we found higher exercise capacity in patients who participated in organized sports. This finding suggests that the children who participate in sports activity may achieve an improved rehabilitation compared with those who are physically less active. However, our finding may also reflect that patients with less sequellae have a higher VO 2peak , allowing participation in sports to a larger extent.
The difference in mean VO 2peak z-score between the group reporting 0 h of sports activity and the group reporting more than 3 h was about 1 z-score. This difference seems clinically significant when taking the patients' perceptions of fitness level into account. Our participants appeared to have a realistic perception of their Peak oxygen uptake after paediatric allogeneic HSCT S Mathiesen et al level of fitness and were aware of being below average. Many survivors of paediatric HSCT experience physical limitations that restrict daily activities and interpersonal relationships. 29 Thus, inability to keep up with peers during regular daily activity may affect the children's quality of life. 7 A few smaller studies have examined the effect of training during the course of HSCT. San Juan et al. 30 demonstrated positive effects on VO 2peak , muscle strength and quality of life during an 8-week intrahospital training programme in children 2-12 months post-HSCT. Rosenhagen et al. 31 trained endurance and strength in children from day 1 to day 14 post HSCT and reported a decreased loss of muscular power, a trend toward better quality of life and reduced fatigue compared with matched controls.
To our knowledge, this is to date the largest study on VO 2peak after HSCT in childhood, performed in a population that recieved a uniform follow-up. The method of VO 2peak measurement used in this study, with direct analysis of expired gas concentrations by mass spectrometry, is considered the gold standard. 32 Some degree of selection bias cannot be excluded as patients with reduced physical capacity may be more prone to avoid participation in research projects. This was however not indicated by differences in age, gender or transplantation characteristics between participants and non-participants, except that a higher proportion of non-participants were treated with BU, which has been associated with pulmonary toxicity. 33 The effects in the total patient population may thus be even more pronounced than suggested by the presented data.
Although HSCT has been described as a risk factor for low VO 2peak , 9 we cannot conclude that the HSCT per se lead to impaired VO 2peak, as morbidity and treatment before HSCT may also influence the results, especially regarding pulmonary performance.
We were not able to identify differences in physical performance in relation to the applied conditioning regimens, in line with the fact that all patients in this study received a toxic and myeloablative conditioning regimen. Although there may be differences in the acute toxicity associated with these regimens, this did, however, not translate into significant differences in physical capacity at follow-up, suggesting that some children may at least partially recover despite previous exposure to highly toxic conditioning regimens. Likewise, we were not able to identify a significant impact of either aGvHD or cGvHD. This finding, however, should be taken with caution because of the limited number of patients with cGvHD and severe aGvHD.
Although we did not identify any risk factors in the transplantation proces that were associated with low VO 2peak , we have identified a long-term complication in these patients that could influence quality of life and be a risk factor of later morbidity, and therefore needs attention at follow-up in these patients.
To overcome the potential weakness of the pooled VO 2peak reference material, we validated the reference values as explained under Materials and methods. In the absence of a single reference material for all age groups concerning D LCO and D LCO /V A , the paediatric reference was extrapolated to ages above 18 years. This could slighty overestimate the diffusion capacities for the youngest adults above 18 years and slightly underestimate for the oldest participants (up to 24 years). Table 2 . Result of the peak oxygen uptake tests in patients 3-10 years post-HSCT (n = 63) and a reference group of healthy subjects (n = 33) The patients mean value is significantly different from the mean value of the healthy subjects, Po0.001. The test duration was aimed at 6-10 min. Ten patients had test duration o 6 min, but fulfilled the criteria of a peak exercise test.
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The ideal exercise test duration is often described as 10 min in adults, although peak values can be reached within a few minutes of heavy exercise. 34 In children, the test should be long enough to fulfil the peak criteria, but short enough to prevent an exercise stop owing to boredom; thus, we aimed for a test duration between 6 and 10 min. Ten patients had shorter test durations, but fulfilled the peak criteria and the tests were therefore accepted.
In conclusion, one fourth of patients had significantly reduced VO 2peak at long-term follow-up after allogeneic HSCT in childhood. The reduced exercise capacity was significantly associated with reduced pulmonary function. However, as the reduced VO 2peak Difference in mean VO 2peak z-score between the groups (x/y) are reported with x value as reference, that is, a negative difference indicates that y has a lower mean value. Figure 4 . VO 2peak z-scores in relation to self-rated fitness level compared with peers (a) and self-reported physical activity (b) from 63 children and young adults 3-10 years post-HSCT. The solid horizontal line in each group represents the mean VO 2peak z-score. The horizontal dashed lines mark the upper and lower limit of normality. Abbreviation: pt ¼ patients.
have multifactorial causes, we expect that despite pulmonary impairment, these patients may increase their exercise capacity by training to strengthen other components in the oxygen transport chain such as cardiac output, capillary density in the muscles and mitochondrial enzyme processes. 35 Higher exercise capacity may lead to less fatigue, improved quality of life and increased motivation for physical activity. Increased physical activity following HSCT may prevent the development of the metabolic syndrome and cardiovascular diseases, as well as osteoporosis, which are all over-represented in children and young adults following HSCT. 1 Further research is needed to investigate whether organized training programs during and after HSCT can improve long-term exercise capacity.
